Placing the search for a cure for HIV/AIDS firmly at the center of its research efforts, amfAR has launched the amfAR Research Consortium on HIV Eradication (ARCHE). This new grant program will support collaborative teams of biomedical researchers exploring strategies for eradicating HIV infection.
"amfAR has a long and successful history of bringing people together to take on the big challenges of HIV/AIDS," says Dr. Rowena Johnston, amfAR’s vice president and director of research. "We’re tremendously excited by this consortium. And we’re confident that this collaborative approach will create a synergy that produces results that exceed what can be generated in individual laboratories."
About ARCHE (Second year)
amfAR Consortium Helps Lead Efforts for HIV/AIDS Cure
About ARCHE (Inaugural year)
amfAR Launches Cure Consortium
ARCHE Research Teams and Their Projects
News and Features
amfAR Symposium Looks to Holy Grail of AIDS Research
amfAR Ramps Up Investment in HIV Cure Research
ARCHE Researchers Prove the Value of Collaboration
The Search for a Cure—Why Now?
Charting a Path to a Cure
amfAR Consortium To Speed Search for HIV/AIDS Cure
The Search for a Cure: An Enduring Commitment
 Dr. Martin Markowitz
at a November 2011 amfAR symposium |
“While others have doubted, amfAR has always believed a cure for AIDS to be possible.”
—Dr. Martin Markowitz, Aaron Diamond AIDS Research Center, New York City